Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	774	650	763	756	572	993
Market Cap Growth	34.69%	-14.84%	0.93%	32.18%	-42.41%	-10.20%
Enterprise Value	777	608	728	702	554	963
Last Close Price	11.25	10.06	11.43	11.03	8.94	15.20
PE Ratio	-	-	-	55.27	35.75	26.30
PS Ratio	2.28	2.19	3.11	3.68	2.88	4.68
PB Ratio	3.23	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	7.47	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	25.69	-	-	35.85	21.10	12.57
P/OCF Ratio	24.94	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.29	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	29.45	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	39.53	-	-	67.70	23.07	12.62
EV/FCF Ratio	25.77	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.54	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	4.35	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	4.26	-	-	7.91	5.97	2.05
Asset Turnover	0.79	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.59	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.04	2.96	3.28	3.90	4.69	3.09
Current Ratio	2.80	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	-3.70%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	2.85%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Capital (ROIC)	3.45%	-0.62%	-3.57%	1.79%	4.29%	18.30%
Return on Capital Employed (ROCE)	5.50%	-	-	2.80%	6.80%	22.30%
Earnings Yield	-1.06%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	3.89%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	-1.47%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q